ANAPTYSBIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.58 USD | +0.91% |
|
+26.57% | +24.09% |
| 16/04 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
| 11/04 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 29.90 | 34.75 | 32.76 |
| Spread/Res. | -11.10% | -23.51% | -18.86% |
| Spread/Supp. | +18.03% | +40.86% | +33.77% |
| Support | 22.52 | 18.87 | 19.87 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ANAB Stock
- Charts AnaptysBio, Inc.
